Prof G Markets: Will Tesla’s Robotaxi Ever Arrive? + Sin Stocks and Zyn Nicotine Pouches

Zyn's Surge

Zyn nicotine pouches have surged in popularity, leading to a significant boost in Philip Morris International's earnings. Ed Mylett highlights that Zyn sales rose 50% year over year, contributing to a 10% increase in the company's total revenue 1. This trend reflects a broader shift towards smoke-free nicotine products, with Zyn being seen as a less harmful alternative to traditional tobacco. Scott Galloway notes, "It's a much less damaging means of delivering nicotine than chewing tobacco" 1.

It's a much less damaging means of delivering nicotine than chewing tobacco.

--- Scott Galloway

Despite its popularity, there are concerns about the lack of long-term data on its health effects, similar to vaping products 2.

   

Ethical Debate

Investing in sin stocks like Philip Morris raises ethical questions, yet they remain attractive due to their profitability. Scott Galloway argues that while these companies may face moral scrutiny, they are often well-managed and provide economic security 3. He states, "I don't have a problem with owning sin stocks," emphasizing the importance of personal choice in investment decisions 2.

I don't have a problem with owning sin stocks.

--- Scott Galloway

This perspective highlights the tension between ethical considerations and financial gain, with Galloway suggesting that the decision ultimately lies with individual investors 3.